These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7273595)

  • 1. Lack of difference in digoxin urinary excretion with two intravenous infusion rates.
    Lindenbaum J; Long R; Wenger T; Mallis G; Cato A
    Clin Pharmacol Ther; 1981 Sep; 30(3):317-20. PubMed ID: 7273595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of nonlinearity in digoxin pharmacokinetics.
    Wagner JG; Popat KD; Das SK; Sakmar E; Movahhed H
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):147-66. PubMed ID: 7277206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of reduced metabolites of digoxin.
    Lindenbaum J; Tse-Eng D; Butler VP; Rund DG
    Am J Med; 1981 Jul; 71(1):67-74. PubMed ID: 7246583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of digoxin from tablets. IV. Urinary excretion of digoxin during multiple dose treatment.
    Nyberg L; Andersson KE; Fagerström PO
    Acta Pharm Suec; 1977; 14(2):119-36. PubMed ID: 906830
    [No Abstract]   [Full Text] [Related]  

  • 8. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- and multiple-dose kinetics of intravenous digoxin.
    Ochs HR; Greenblatt DJ; Bodem G
    Clin Pharmacol Ther; 1980 Sep; 28(3):340-5. PubMed ID: 7408393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of one- and six-day urinary digoxin excretion in single-dose bioavailability studies.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):813-6. PubMed ID: 4426150
    [No Abstract]   [Full Text] [Related]  

  • 11. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative bioavailability of three pharmaceutical forms of digoxin].
    Thebault J; Lucas A; d'Athis P; Tillement JP
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):144-7. PubMed ID: 576592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intersubject variation in absorption of digoxin in normal volunteers.
    Huffman DH; Manion CV; Azarnoff DL
    J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetic parameters of digoxin and SC4453 a digoxin analogue, following a single bolus i.v. dose and following an infusion preceeded by an i.v. loading dose in the guinea-pig.
    Randimbivololona F; Lesne M
    J Pharmacol; 1983; 14(1):9-17. PubMed ID: 6834854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological availability of diagoxin in patients with or without gastric resection (Billroth II) (author's transl)].
    Ochs H; Bodem G; Kodrat G; Savic B; Baur MP
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2430-4. PubMed ID: 810339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous furosemide on the renal excretion of digoxin.
    McAllister RG; Howell SM; Gomer MS; Selby JB
    J Clin Pharmacol; 1976; 16(2-3):110-7. PubMed ID: 943423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A routine method for the determination of digoxin in urine by radioimmunoassay.
    Christenson RH; Hammond JE; Hull JH; Bustrack JA
    Clin Chim Acta; 1982 Mar; 120(1):13-9. PubMed ID: 7067133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dose on bioavailability of oral digoxin.
    Ochs HR; Bodem G; Greenblatt DJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):53-5. PubMed ID: 7461024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
    Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.